Bridgeway Capital Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,265
Closed -$72.8K 1428
2023
Q1
$72.8K Hold
10,265
﹤0.01% 1279
2022
Q4
$65.9K Hold
10,265
﹤0.01% 1274
2022
Q3
$150K Hold
10,265
﹤0.01% 1197
2022
Q2
$185K Hold
10,265
﹤0.01% 1107
2022
Q1
$306K Buy
+10,265
New +$306K 0.01% 1074
2021
Q3
Sell
-5,265
Closed -$604K 1329
2021
Q2
$604K Sell
5,265
-4,750
-47% -$545K 0.01% 1016
2021
Q1
$1.04M Sell
10,015
-2,750
-22% -$286K 0.02% 848
2020
Q4
$610K Hold
12,765
0.01% 878
2020
Q3
$355K Buy
12,765
+5,000
+64% +$139K 0.01% 1004
2020
Q2
$297K Sell
7,765
-3,750
-33% -$143K 0.01% 1042
2020
Q1
$564K Hold
11,515
0.01% 728
2019
Q4
$518K Sell
11,515
-2,000
-15% -$90K 0.01% 978
2019
Q3
$568K Buy
13,515
+5,000
+59% +$210K 0.01% 904
2019
Q2
$424K Sell
8,515
-1,235
-13% -$61.5K 0.01% 1020
2019
Q1
$770K Hold
9,750
0.01% 858
2018
Q4
$269K Sell
9,750
-5,250
-35% -$145K ﹤0.01% 1160
2018
Q3
$750K Hold
15,000
0.01% 1012
2018
Q2
$765K Buy
15,000
+9,250
+161% +$472K 0.01% 985
2018
Q1
$242K Sell
5,750
-1,500
-21% -$63.1K ﹤0.01% 1245
2017
Q4
$674K Hold
7,250
0.01% 996
2017
Q3
$1.1M Hold
7,250
0.01% 812
2017
Q2
$754K Hold
7,250
0.01% 944
2017
Q1
$866K Buy
7,250
+2,250
+45% +$269K 0.01% 864
2016
Q4
$705K Hold
5,000
0.01% 945
2016
Q3
$504K Hold
5,000
0.01% 1102
2016
Q2
$356K Buy
+5,000
New +$356K 0.01% 1177